Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
APLP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
POLR2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK4-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CD2BP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LARS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMNB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF4ENIF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCNX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYNE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMAD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BUD31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on